Literature DB >> 24221338

Down-regulation of PTEN expression modulated by dysregulated miR-21 contributes to the progression of esophageal cancer.

Pei Li1, Wei-Min Mao, Zhi-Guo Zheng, Zi-Ming Dong, Zhi-Qiang Ling.   

Abstract

BACKGROUND AND AIM: miR-21, a putative tumor oncomiR, is a frequently overexpressed miRNA in a variety of tumors. Because it targets tumor-suppressor genes it has been linked to tumor progression. In this study we investigated the role of miR-21 in esophageal squamous cell carcinoma (ESCC), and its possible mechanism.
METHODS: Expression of miR-21 was detected by stem-loop RT-PCR in tissue from 76 invasive ESCC at stage I-IV and in their corresponding para-cancerous histological normal tissues (PCHNT). Thirty endoscopic esophageal mucosal biopsy specimens from non-tumor patients were used as controls. Expression of PTEN in 76 paired ESCC and PCHNT was investigated by real-time RT-PCR and an immunohistochemical method, respectively. Paired tumor and PCHNT specimens of 20 ESCC cases were randomly selected for western blot analysis. The effect of miR-21 on PTEN expression was assessed in the ESCC cell line with an miR-21 inhibitor to reduce miR-21 expression. Furthermore, the roles of miR-21 in cell biology were analyzed by use of miR-21 inhibitor-transfected cells.
RESULTS: Stem-loop RT-PCR revealed miR-21 was significantly overexpressed in ESCC tissues and cell lines. Overexpression of miR-21 correlated with tumor status, lymph node metastasis, and clinical stage. We demonstrated that knockdown of miR-21 significantly increased expression of PTEN protein. Consequent PTEN expression reduced cell proliferation, invasion, and migration.
CONCLUSIONS: Our findings suggest that miR-21 could be a potential oncomiR, probably by regulation of PTEN, and a novel prognostic factor for ESCC patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24221338     DOI: 10.1007/s10620-013-2854-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  50 in total

1.  Relationships between esophageal cancer and spatial environment factors by using Geographic Information System.

Authors:  Ku-Sheng Wu; Xia Huo; Guang-Hui Zhu
Journal:  Sci Total Environ       Date:  2008-02-19       Impact factor: 7.963

2.  MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein.

Authors:  Yanhui Lou; Xingsheng Yang; Fuling Wang; Zhumei Cui; Yu Huang
Journal:  Int J Mol Med       Date:  2010-12       Impact factor: 4.101

3.  MicroRNA expression profiles in serous ovarian carcinoma.

Authors:  Eun Ji Nam; Heejei Yoon; Sang Wun Kim; Hoguen Kim; Young Tae Kim; Jae Hoon Kim; Jae Wook Kim; Sunghoon Kim
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

4.  MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.

Authors:  Changzheng Liu; Jia Yu; Shuangni Yu; Robert M Lavker; Lei Cai; Wei Liu; Kegong Yang; Xiaodong He; Songsen Chen
Journal:  J Hepatol       Date:  2010-04-04       Impact factor: 25.083

5.  Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma.

Authors:  Youhei Tanaka; Hidenobu Kamohara; Kouichi Kinoshita; Junji Kurashige; Takatsugu Ishimoto; Masaaki Iwatsuki; Masayuki Watanabe; Hideo Baba
Journal:  Cancer       Date:  2012-12-07       Impact factor: 6.860

6.  Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China.

Authors:  Yan-Ru Qin; Li-Dong Wang; Zong-Min Fan; Dora Kwong; Xin-Yuan Guan
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

7.  MiR-21 expression in the tumor cell compartment holds unfavorable prognostic value in gliomas.

Authors:  Simon Kjær Hermansen; Rikke Hedegaard Dahlrot; Boye Schnack Nielsen; Steinbjørn Hansen; Bjarne Winther Kristensen
Journal:  J Neurooncol       Date:  2012-10-28       Impact factor: 4.130

8.  miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN.

Authors:  Shou-Mei Yang; Cheng Huang; Xiao-Feng Li; Ming-Zhe Yu; Yong He; Jun Li
Journal:  Toxicology       Date:  2013-03-04       Impact factor: 4.221

9.  Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway.

Authors:  Sandeep Sheth; Sarvesh Jajoo; Tejbeer Kaur; Debashree Mukherjea; Kelly Sheehan; Leonard P Rybak; Vickram Ramkumar
Journal:  PLoS One       Date:  2012-12-13       Impact factor: 3.240

10.  Prognostic Implications of MicroRNA-21 Overexpression in Invasive Ductal Carcinomas of the Breast.

Authors:  Jung Ah Lee; Hye Yoon Lee; Eun Sook Lee; Insun Kim; Jeoung Won Bae
Journal:  J Breast Cancer       Date:  2011-12-27       Impact factor: 3.588

View more
  26 in total

Review 1.  The role of microRNA in esophageal squamous cell carcinoma.

Authors:  Kazuto Harada; Yoshifumi Baba; Takatsugu Ishimoto; Hironobu Shigaki; Keisuke Kosumi; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  J Gastroenterol       Date:  2016-01-21       Impact factor: 7.527

2.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

3.  Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury.

Authors:  Zhihui Li; Xu Deng; Zhijuan Kang; Ying Wang; Tuanhong Xia; Niu Ding; Yan Yin
Journal:  J Nephrol       Date:  2015-07-07       Impact factor: 3.902

Review 4.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Authors:  Ya-Kai Huang; Jian-Chun Yu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 5.  Roles of PTEN inactivation and PD-1/PD-L1 activation in esophageal squamous cell carcinoma.

Authors:  Rong Qiu; Wenxi Wang; Juan Li; Yuxiang Wang
Journal:  Mol Biol Rep       Date:  2022-03-17       Impact factor: 2.742

6.  MicroRNA-21 promotes cell proliferation, migration, and resistance to apoptosis through PTEN/PI3K/AKT signaling pathway in esophageal cancer.

Authors:  Yan-Ran Wu; Hai-Jun Qi; Dan-Fang Deng; Ying-Ying Luo; Sheng-Lan Yang
Journal:  Tumour Biol       Date:  2016-05-17

7.  miR-21 regulates tumor progression through the miR-21-PDCD4-Stat3 pathway in human salivary adenoid cystic carcinoma.

Authors:  Lie-Hao Jiang; Ming-Hua Ge; Xiu-Xiu Hou; Jun Cao; Si-Si Hu; Xiao-Xiao Lu; Jing Han; Yi-Chen Wu; Xiang Liu; Xin Zhu; Lian-Lian Hong; Pei Li; Zhi-Qiang Ling
Journal:  Lab Invest       Date:  2015-09-14       Impact factor: 5.662

8.  MicroRNA-148a represents an independent prognostic marker in bladder cancer.

Authors:  Lin Ma; Zhishun Xu; Chao Xu; Xianzhou Jiang
Journal:  Tumour Biol       Date:  2015-12-23

Review 9.  MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker.

Authors:  Ha Thi Nguyen; Salah Eddine Oussama Kacimi; Truc Ly Nguyen; Kamrul Hassan Suman; Roselyn Lemus-Martin; Humaira Saleem; Duy Ngoc Do
Journal:  Biology (Basel)       Date:  2021-05-08

10.  The microRNA miR-21 conditions the brain to protect against ischemic and traumatic injuries.

Authors:  Mary S Lopez; Robert J Dempsey; Raghu Vemuganti
Journal:  Cond Med       Date:  2017-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.